Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese

被引:206
作者
Kawaguchi, Takahisa [1 ,2 ]
Sumida, Yoshio [3 ]
Umemura, Atsushi [4 ]
Matsuo, Keitaro [5 ]
Takahashi, Meiko [1 ]
Takamura, Toshinari [6 ]
Yasui, Kohichiroh [7 ]
Saibara, Toshiji
Hashimoto, Etsuko [9 ]
Kawanaka, Miwa [10 ]
Watanabe, Sumio [2 ]
Kawata, Sumio [11 ,12 ]
Imai, Yasuharu [13 ]
Kokubo, Miki [1 ]
Shima, Toshihide [4 ,8 ]
Park, Hyohun [4 ]
Tanaka, Hideo [5 ]
Tajima, Kazuo [5 ]
Yamada, Ryo [1 ]
Matsuda, Fumihiko [1 ,2 ]
Okanoue, Takeshi [4 ]
机构
[1] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan
[2] Kyoto Univ, Grad Sch Med, INSERM, U852, Kyoto, Japan
[3] Nara City Hosp, Ctr Digest & Liver Dis, Nara, Japan
[4] Saiseikai Suita Hosp, Ctr Gastroenterol & Hepatol, Suita, Osaka, Japan
[5] Aichi Canc Ctr, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan
[6] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan
[7] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kyoto, Japan
[8] Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan
[9] Tokyo Womens Med Univ, Dept Internal Med & Gastroenterol, Tokyo, Japan
[10] Kawasaki Med Sch, Kawasaki Hosp, Ctr Liver Dis, Okayama, Japan
[11] Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 113, Japan
[12] Yamagata Univ, Sch Med, Dept Gastroenterol, Yamagata 99023, Japan
[13] Ikeda Municipal Hosp, Dept Internal Med, Ikeda, Osaka, Japan
关键词
STEATOHEPATITIS; SUSCEPTIBILITY; VARIANT; I148M;
D O I
10.1371/journal.pone.0038322
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Background: Nonalcoholic fatty liver disease (NAFLD) includes a broad range of liver pathologies from simple steatosis to cirrhosis and fibrosis, in which a subtype accompanying hepatocyte degeneration and fibrosis is classified as nonalcoholic steatohepatitis (NASH). NASH accounts for approximately 10-30% of NAFLD and causes a higher frequency of liver-related death, and its progression of NASH has been considered to be complex involving multiple genetic factors interacting with the environment and lifestyle. Principal Findings: To identify genetic factors related to NAFLD in the Japanese, we performed a genome-wide association study recruiting 529 histologically diagnosed NAFLD patients and 932 population controls. A significant association was observed for a cluster of SNPs in PNPLA3 on chromosome 22q13 with the strongest p-value of 1.4x10(-10) (OR = 1.66, 95%CI: 1.43-1.94) for rs738409. Rs738409 also showed the strongest association (p = 3.6x10(-6)) with the histological classifications proposed by Matteoni and colleagues based on the degree of inflammation, ballooning degeneration, fibrosis and Mallory-Denk body. In addition, there were marked differences in rs738409 genotype distributions between type4 subgroup corresponding to NASH and the other three subgroups (p = 4.8x10(-6), OR = 1.96, 95%CI: 1.47-2.62). Moreover, a subgroup analysis of NAFLD patients against controls showed a significant association of rs738409 with type4 (p = 1.7x10(-16), OR = 2.18, 95%CI: 1.81-2.63) whereas no association was obtained for type1 to type3 (p = 0.41). Rs738409 also showed strong associations with three clinical traits related to the prognosis of NAFLD, namely, levels of hyaluronic acid (p = 4.6x10(-4)), HbA1c (p = 0.0011) and iron deposition in the liver (p = 5.6x10(-4)). Conclusions: With these results we clearly demonstrated that Matteoni type4 NAFLD is both a genetically and clinically different subset from the other spectrums of the disease and that the PNPLA3 gene is strongly associated with the progression of NASH in Japanese population.
引用
收藏
页数:10
相关论文
共 26 条
[1]
Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[2]
Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes [J].
Berson, A ;
De Beco, V ;
Lettéron, P ;
Robin, MA ;
Moreau, C ;
El Kahwaji, J ;
Verthier, N ;
Feldmann, G ;
Fromenty, B ;
Pessayre, D .
GASTROENTEROLOGY, 1998, 114 (04) :764-774
[3]
Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x
[4]
Human Fatty Liver Disease: Old Questions and New Insights [J].
Cohen, Jonathan C. ;
Horton, Jay D. ;
Hobbs, Helen H. .
SCIENCE, 2011, 332 (6037) :1519-1523
[5]
From fat to inflammation [J].
Day, CP .
GASTROENTEROLOGY, 2006, 130 (01) :207-210
[6]
Genomic control for association studies [J].
Devlin, B ;
Roeder, K .
BIOMETRICS, 1999, 55 (04) :997-1004
[7]
A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis [J].
He, Shaoqing ;
McPhaul, Christopher ;
Li, John Zhong ;
Garuti, Rita ;
Kinch, Lisa ;
Grishin, Nick V. ;
Cohen, Jonathan C. ;
Hobbs, Helen H. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (09) :6706-6715
[8]
Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease [J].
Hotta, Kikuko ;
Yoneda, Masato ;
Hyogo, Hideyuki ;
Ochi, Hidenori ;
Mizusawa, Seiho ;
Ueno, Takato ;
Chayama, Kazuaki ;
Nakajima, Atsushi ;
Nakao, Kazuwa ;
Sekine, Akihiro .
BMC MEDICAL GENETICS, 2010, 11
[9]
LUDWIG J, 1980, MAYO CLIN PROC, V55, P434
[10]
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity [J].
Matteoni, CA ;
Younossi, ZM ;
Gramlich, T ;
Boparai, N ;
Liu, YC ;
McCullough, AJ .
GASTROENTEROLOGY, 1999, 116 (06) :1413-1419